Business Wire

Echosens Presents Symposium & Democenter at EASL International Liver Congress™ 2022: FibroScan ® Solutions Bringing New Guidelines to Life, New FibroScan GO Demonstrations

Share

Echosens, a high-technology company offering the FibroScan® portfolio of solutions, is pleased to announce its solutions will be included in 22 oral presentations and 157 posters that will evaluate utilization of the non-invasive FibroScan® tool across a variety of liver disease etiologies and practice settings at EASL International Liver Congress™ 2022, June 22-26, 2022, London, United Kingdom. Echosens leaders will present the symposium “FibroScan® Solutions Bringing New Guidelines to Life,” 11 a.m.-12:30 p.m., Meeting Room N19, ExCel London Center, on June 23. Additionally, Echosens will offer “How to Improve Early Screening and Management of Chronic Liver Disease Outside Hospital Setting?” -- two demonstrations of FibroScan® GO, 3 p.m.-4 p.m. or 5:30 p.m.-6:30 p.m. on June 23 in Meeting Room N19, ExCel London.

“This very important meeting furthers the worldwide understanding of liver research, enhances the clinical practice of liver disorders and educates those interested in hepatology,” says Dominique Legros, Group CEO, Echosens. “FibroScan®, the non-invasive solution for comprehensive management of liver health, is recognized worldwide, validated by over 3,500 peer reviewed publications and 160 international guidelines and considered the most widely studied tool for point of care liver assessment.”

Echosens will be available at booth N°46 to discuss and demonstrate early detection with new FibroScan GO, diagnosing and monitoring with FibroScan Mini+ 430 and FibroScan Compact 530, advanced diagnosis and risk stratification with FibroScan Expert 630 live patient demonstration, and digital demonstrations of myFibroScan and Scores by Echosens.

Jon Gingrich, CEO, Echosens North America, adds, “We are thrilled by the global validation of FibroScan and broad consensus of the need for screening and early intervention to prevent advanced liver disease. FibroScan can more cost-effectively identify individuals who are asymptomatic and undiagnosed for liver damage, as well as provide metrics for monitoring changes in liver fat due to lifestyle modification.”

About Echosens

Pioneer in its field, Echosens significantly changed the practice of liver assessment with FibroScan®, the non-invasive solution for comprehensive management of liver health. FibroScan® is recognized worldwide and validated by over 3,500 peer reviewed publications and 160 international guidelines. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide. https://www.echosens.com/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media:
Brittany Tedesco
CPR Communications
btedesco@cpronline.com
201.641.1911 x 14

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Esri Recognizes Italian Rail Agency for Modernizing Infrastructure6.7.2022 15:50:00 CEST | Press release

Last year, the Italian rail agency Rete Ferroviaria Italiana (RFI) built an application using geographic information system (GIS) technology from Esri, the global leader in location intelligence. Called StationLAND, the application is designed to make railway stations the centerpieces of their communities by increasing connectivity to the stations themselves within towns and cities. StationLAND improves the understanding of how and why rail stations work and how they can work better. StationLAND was designed to address a very specific need. "In Italy, the railways are one of the things that work best. What lagged was our stations," said Luigi Contestabile, RFI head of facilities, who also led the team that built the application. As a result, RFI sought to use technology to understand how rail stations could be better connected to their communities, thereby encouraging more rail travel. "The stations' centricity in our planning is fundamental to developing the sustainable intermodality

Globality Named Best Innovative Provider at Trophées des Achats Procurement Awards6.7.2022 15:42:00 CEST | Press release

Globality, the company transforming the way global enterprises buy services with its leading AI-powered digital solution, was recently named “Lauréat d’Or”, or “Best Innovative Provider”, at the prestigious Trophées des Achats awards ceremony in Paris. Organised annually since 2007 by Republik, the Trophées des Achats is regarded as a leading procurement event in France with more than 900 procurement professionals gathering each year to celebrate the most innovative technology and solutions transforming the procurement industry. More than 60 companies competed across three categories with the Innovative Provider category rewarding the digital solutions which are improving the performance of procurement teams at leading global organizations. Globality received its award from the Chief Procurement Officer (CPO) of France Television, Ahlem Hamdi and Bertrand Pouilloux, CPO of Enedis. Other members of the jury included Veolia CPO Sophie Gour, Yasser Balawi, CPO at Sodiaal, Siemens CPO Oliv

Travelex Bank Selects ThetaRay for Transaction Monitoring and Sanctions Screening6.7.2022 14:00:00 CEST | Press release

ThetaRay, a leading provider of AI-powered transaction monitoring technology, today announced that Travelex Bank, Brazil’s largest foreign exchange specialist, will implement ThetaRay’s SONAR anti-money laundering (AML) SaaS solution for both domestic and international transaction monitoring, as well as real-time sanctions screening for its international payments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220706005020/en/ Travelex Exchange Service (Photo: Business Wire) Travelex Bank is one of the world’s leading specialist providers of foreign exchange, offering a range of international money transfer products including import/export, remittances and mass payments. SONAR will empower Travelex Bank to detect attempts to launder money or circumvent financial sanctions through its system, bringing trust and confidence to all parties in the global payments ecosystem. Additionally, SONAR will allow the company to roll out n

BigCommerce utvider det globale avtrykket til Danmark, Norge, Sverige og Østerrike for å gi selgere mulighet til å skalere og få nettbutikkene sine til å vokse6.7.2022 14:00:00 CEST | Pressemelding

BigCommerce (Nasdaq: BIGC), en ledende åpen SaaS netthandelsplattform for raskt voksende og etablerte B2C- og B2B-varemerker, kunngjorde i dag at de har utvidet deres europeiske tilstedeværelse til Østerrike, Danmark, Norge og Sverige. Med sin DACH og nordiske ekspansjon og fullt lokaliserte teknologi- og byråpartner-økosystem, vil BigCommerce gjøre det mulig for selgere i alle størrelser og kompleksiteter å bygge og skalere nettbedriftene sine for å gi sømløse handleopplevelser til lokale og internasjonale kunder og øke inntektene. "BigCommerces nye tilstedeværelse i DACH og nordiske markeder gir en lokalisert, kraftig og skalerbar åpen SaaS netthandelsplattform til selgere i disse regionene som ikke tidligere har blitt tilbudt disse kjerneprinsippene i én løsning," sa Jim Herbert, senior visepresident og daglig leder EMEA hos BigCommerce. «Med vår velprøvde netthandelsplattform i enterprise-grad, vil selgere av alle typer ha de gode verktøyene og innovative funksjonalitetene – fra he

KBI Biopharma and Selexis Hold Joint Ribbon Cutting of the Expanded State-of-the-Art Facility in Geneva, Switzerland6.7.2022 13:45:00 CEST | Press release

KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, held a joint ribbon-cutting ceremony yesterday at their new state-of-the-art facility in Geneva, Switzerland. Designed to directly serve the increased demand for biopharmaceutical drug development and manufacturing in Europe, the facility will support an integrated, end-to-end process of Selexis’ cell line development (CLD) services along with KBI’s contract development and manufacturing services for industry clients throughout the immediate region and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220706005082/en/ KBI Biopharma and Selexis ribbon cutting at their new state-of-the-art facility in Geneva, Switzerland, Tuesday, July 5, 2022 (from left to right: Mark Lutgen, KBI Biopharma, VP of Global Engineering; Mario Rodriguez, Mayor, Plan-les-Ouates; Fabienne Fischer, State Councilor and Head of the Department of the Economy and Employment; Ma